Complete Response in Metastatic Hepatocellular Carcinoma with Cardiac and Lung Involvement via Multimodality Treatment.

Kun-Feng Tsai, Jerry C H Tsai, Ming-Feng Li, Jimmy W H Tan, Chu-Kuang Chou, Huei-Lung Liang, Shan-Ho Chan

Abstract readCase Reports

In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Immunotherapy Plus Locoregional Therapy Leading to Curative-Intent Hepatectomy in HCC: Proof of Concept Producing Durable Survival Benefits Detectable with Liquid Biopsy.Cancers · 2023
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kun-Feng TsaiGastroenterology and Hepatology Section, Department of Internal Medicine, An Nan Hospital, China Medical University, Tainan 709, Taiwan.

Jerry C H TsaiDepartment of Radiology, New Taipei City Hospital-Sanchong Branch, New Taipei City 241, Taiwan.ORCID 0000-0003-4141-4982

Ming-Feng LiDepartment of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.ORCID 0000-0003-3472-9070

Jimmy W H TanDivision of Cardiovascular Surgery, An Nan Hospital, China Medical University, Tainan 709, Taiwan.

Chu-Kuang ChouDivision of Gastroenterology and Hepatology and Clinical Trial Center, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi 600, Taiwan.ORCID 0000-0003-2588-6883

Huei-Lung LiangDepartment of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung 813, Taiwan.

Shan-Ho ChanDepartment of Medical Imaging and Radiology, Shu-Zen Junior College of Medicine and Management, Kaohsiung 821, Taiwan.

Funding

An Nan Hospital research fund ANHRF107-25

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsHeart AtriaHumansLungMaleMiddle AgedVena Cava, Inferiormetastatic hepatocellular carcinomamultimodality treatmenttumor thrombi in inferior vena cava or right atrium

Identifiers

PMID34441054

DOI10.3390/medicina57080849

PMCPMC8399561

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.